BiomX Inc.
PHGE · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $292 | $0 | $0 |
| Gross Profit | $0 | -$292 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,122 | $5,014 | $5,250 | $11,570 |
| G&A Expenses | $0 | $2,419 | $2,506 | $1,539 |
| SG&A Expenses | $2,414 | $2,419 | $2,506 | $6,032 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $4,493 |
| Other Operating Expenses | $0 | -$292 | $0 | -$34,287 |
| Operating Expenses | $8,536 | $7,141 | $7,756 | -$16,685 |
| Operating Income | -$8,536 | -$7,433 | -$7,756 | $16,685 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$627 | $1,398 | $98 | -$31,195 |
| Pre-Tax Income | -$9,163 | -$6,035 | -$7,658 | -$14,510 |
| Tax Expense | $3 | $2 | $1 | $3 |
| Net Income | -$9,166 | -$6,037 | -$7,659 | -$14,513 |
| % Margin | – | – | – | – |
| EPS | -0.051 | -3.61 | -6.27 | -3.99 |
| % Growth | 98.6% | 42.4% | -57.1% | – |
| EPS Diluted | 5.51 | -3.61 | -6.27 | -15.2 |
| Weighted Avg Shares Out | 1,648 | 1,648 | 1,216 | 3,674 |
| Weighted Avg Shares Out Dil | 1,652,608 | 1,648 | 1,215,953 | 9,567 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $30 | $810 | $5 |
| Depreciation & Amortization | $0 | $292 | $236 | $921 |
| EBITDA | -$9,158 | -$5,713 | -$7,417 | -$7,593 |
| % Margin | – | – | – | – |